Litcius/Paper detail

Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers

Alberto Martín, Carolina Epifano, Borja Vilaplana‐Martí, Iván Hernández, Rocı́o I.R. Macı́as, Ángel Martínez‐Ramírez, Ana Cerezo, Pablo Cabezas‐Sainz, María Garranzo‐Asensio, Sandra Amarilla‐Quintana, Déborah Gómez-Domínguez, Eduardo Caleiras, Jordi Camps, Gonzalo Goméz-López, Marta Gómez de Cedrón, Ana Ramı́rez de Molina, Rodrigo Barderas, Laura Sánchez, Susana Velasco-Miguel, Ignacío Pérez de Castro

2022Cell Death and Differentiation26 citationsDOIOpen Access PDF

Topics & Concepts

AneuploidyBiologyTelomeraseCancer researchChromosome instabilityCancerCancer cellGenome instabilityBiomarkerRNADNA damageCell biologyGeneticsDNAGeneChromosomeRNA modifications and cancerRNA Research and SplicingCancer-related molecular mechanisms research
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers | Litcius